What is XERS's dilution risk score?

XERS has a latest available DilutionScore record of 27/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for XERS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for XERS?

DilutionWatch tracks 25 SEC filing types for XERS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect XERS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For XERS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for XERS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for XERS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

XERS Dilution Risk Score: 27/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

25

📊 Float Risk

2

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for XERS.

🔔 Track XERS — Get forecast alerts →

Market Data

Market Cap$1.06B

Shares Outstanding182.32M

Float163.84M

Cash$121.75M

Debt$252.59M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 14.0% shares (2026Q1 vs prior)

240 institutional holders · 118.06M shares

#1 BlackRock, Inc. 12.95M shares

#2 MORGAN STANLEY 8.50M shares

#3 D. E. Shaw & Co., Inc. 7.79M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.22M

Days to Cover6.8

% of Float5.6%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2025-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual XERS Dilution Snapshot

Xeris Biopharma Holdings, Inc. (XERS) has a DilutionScore of 27/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 263,158.
Recent SEC activity tracked for XERS: xbrl on 2026-06-30; xbrl on 2025-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.